Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Boston Therapeutics (BTHE)

Boston Therapeutics (BTHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,111
  • Shares Outstanding, K 111,131
  • Annual Sales, $ 10 K
  • Annual Income, $ -910 K
  • 60-Month Beta 0.20
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTHE with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 12/27/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0091 +9.89%
on 11/12/21
0.0274 -63.50%
on 11/05/21
-0.0090 (-47.37%)
since 10/12/21
3-Month
0.0081 +23.46%
on 09/29/21
0.0300 -66.67%
on 08/18/21
-0.0083 (-45.36%)
since 08/12/21
52-Week
0.0055 +81.82%
on 12/17/20
0.0670 -85.07%
on 01/27/21
+0.0040 (+66.67%)
since 11/11/20

Most Recent Stories

More News
Nanomix Completes Changes to Corporate Name and Ticker Symbol

Nanomix Corporation (OTCBB: NNMX) (“Nanomix” or the “Company”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced the completion of its name change...

NNMX : 0.0001 (unch)
BTHE : 0.0100 (unch)
Boston Therapeutics Announces $8.4 Million Convertible Placement in Conjunction with Nanomix Reverse Merger

Boston Therapeutics, Inc. (the “Company”) (OTCQB:BTHE) and merger partner Nanomix, Inc. (“Nanomix”), a leader in the development of mobile, affordable, point-of-care diagnostics, today announced...

BTHE : 0.0100 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Boston Therapeutics, Inc. is a pharmaceutical company engaged in the development, manufacturing, and commercialization of compounds for the treatment of diabetes and inflammatory diseases. The Company focuses on glyco-pathology. Its product portfolio includes SUGARDOWN(R), PAZ320 and IPOXYN(TM). Boston...

See More

Key Turning Points

3rd Resistance Point 0.0144
2nd Resistance Point 0.0131
1st Resistance Point 0.0116
Last Price 0.0100
1st Support Level 0.0088
2nd Support Level 0.0075
3rd Support Level 0.0060

See More

52-Week High 0.0670
Fibonacci 61.8% 0.0435
Fibonacci 50% 0.0363
Fibonacci 38.2% 0.0290
Last Price 0.0100
52-Week Low 0.0055

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar